PRAX (Praxis Corp) Bozor qiymatining balans qiymatiga nisbati
Praxis Precision Medicines (PRAX) AI modellashtirish va bioskrining orqali nevrologik dori formulalarini kashf etishni avtomatlashtiradi, bunda ion kanallarini tahlil qilish orqali kam uchraydigan motor patologiyalari va epilepsiya uchun maqsadli terapiyalarni ishlab chiqishga e'tibor qaratadi. GURU.Markets platformasidagi aksiyalar narxi tarixi hozirda 5.58 darajasida turibdi. Biznesning joriy holati yangi kichik molekulyar agentlar klinik sinovlardan o'tayotgan bir paytda mavjud kapital rezervlariga tayanadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_PRAX_-_Praxis-Precision-Medicines_-_Capitalization-to-Book-Value-Ratio "PRAX Praxis Precision Medicines, Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Praxis Precision Medicines Inc (PRAX) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Praxis Precision Medicines|PRAX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Praxis Medicines|PRAX - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Praxis Medicines|PRAX - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzi Praxis Precision Medicines
Fundamental baholash:PRAX Praxis Precision Medicines
Barqaror aktivlarning professional tanlovi spekulyativ buzilishlarni bartaraf etish uchun bozor baholashini haqiqiy sof aktivlar qiymati bilan solishtirishga asoslanadi. Buxgalteriya qiymatiga nisbatan narx koeffitsiyentini tahlil qilish orqali investor kapital uchun to'langan premiumni baholaydi, bu esa Praxis Precision Medicines (PRAX) uchun ulixacaltamide klinika sinovlari natijalari kutilayotgan vaqtda tadqiqot va ishlanmalar (R&D) infratuzilmasi hamda naqd pul rezervlarining qiymatini aniqlashda muhim ahamiyatga ega.
Toʻgʻridan-toʻgʻri raqobatchilar
Kapitallashuvning sof aktivlarga nisbati Biogen Inc.|NBIX (neurocrine.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|BHVN (Biohaven Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals AMLX|Sof aktivlarga nisbatan bozor kapitallashuvi TRVI|Anavex Life Sciences Corp. (AVXL) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CeriBell Inc (CBLL)|Bozor kapitallashuvining balans qiymatiga nisbati PRTA (prothena.com)|ALEC - Bozor kapitallashuvining balans qiymatiga nisbati|Annexon, Inc. (ANNX) - Kapitallashuvning sof aktivlarga nisbati|OMER - Kapitallashuvning balans qiymatiga nisbati|Neurogene - Bozor kapitallashuvining balans qiymatiga nisbati|ACIU (AC Immune S.A.) - Balans qiymatiga nisbatan bozor kapitallashuvi|VYGR: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Neumora Corp (NMRA)|Scilex Holding Company (SCLX) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TVGN (tevogen.com)|Alpha Cognition Inc. (ACOG) - Bozor qiymatining balans qiymatiga nisbati|cogrx.com - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Inhibikase (IKT)|SAVA - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ASRT|Coya Therapeutics (COYA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati VTGN|Kapitallashuvning sof aktivlarga nisbati Ovid Rx|ABOS (Acumen Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CRVO (CervoMed Corporation)|Bozor qiymatining balans qiymatiga nisbati ATHE|Balans qiymatiga nisbatan bozor kapitallashuvi Clene Inc CLNN|Bozor kapitallashuvining balans qiymatiga nisbati PEPG (PepGen Corp)|JUNS: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati RLMD|ANVS (Annovis Bio Corporation) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Grace Therapeutics Inc (GRCE)|Kapitallashuvning balans qiymatiga nisbati fireflyneuro.com (AIFF)|Klotho Neurosciences Inc (KLTO) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati NRSN (neurosense-tx.com)|Reviva Pharmaceuticals Holdings - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati MetaVia Inc. MTVA|NRXS (NeurAxis, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|HSDT - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati passagebio.com|Neuphoria Therapeutics (NEUP) - Kapitallashuvning balans qiymatiga nisbati|NERV: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Athira Pharma Corp|Bozor kapitallashuvining balans qiymatiga nisbati ADXN (Addex Therapeutics)|Kapitallashuvning sof aktivlarga nisbati alzamend.com (ALZN)|Bozor kapitallashuvining balans qiymatiga nisbati CYCN|Protagenic Therapeutics Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi|Pasithea (KTTA) - Bozor qiymatining balans qiymatiga nisbati|CRGT - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATXI|BCLI (brainstorm-cell.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CARA: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CHRO|ELYM - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ITCI (intracellulartherapies.com)|Bozor qiymatining balans qiymatiga nisbati Longboard Pharmaceuticals|Balans qiymatiga nisbatan bozor qiymati marinuspharma.com MRNS|NKGen Biotech - Bozor kapitallashuvining balans qiymatiga nisbati|NeuroBo Pharmaceuticals Inc (NRBO) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Sage Therapeutics, Inc|SNPX (Synaptogenix, Inc) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc. (TRVN)|Kapitallashuvning balans qiymatiga nisbati Vigil Neuro|Anew Medical, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cerevel Therapeutics Inc CERE